Literature DB >> 3779635

Involvement of protein kinase C activation in ornithine decarboxylase gene expression in primary culture of newborn mouse epidermal cells and in skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.

A K Verma, R C Pong, D Erickson.   

Abstract

The role of protein kinase C in ornithine decarboxylase (ODC; EC 4.1.1.17) gene expression in primary culture of newborn mouse epidermal cells (MEC) from BALB/c mice and in skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate (TPA) in female CD-1 mice was determined. A time course and the dose-response curves of ODC induction paralleled that of ODC mRNA induction by TPA in MEC. TPA treatment did not elicit any change in the size of ODC mRNA. The magnitude of ODC induction was proportional to the amount of ODC mRNA increased by TPA. TPA (2 X 10(-7) M) failed to induce ODC activity in MEC plated in Ca2+-deprived medium; TPA induction of ODC could be resumed upon Ca2+ restoration in the medium. 1-Oleoyl-2-acetylglycerol, a membrane-permeable diacylglycerol which activates protein kinase C, induced at the same rate both ODC activity and the amount of ODC mRNA in MEC. Phospholipase C, which releases diacylglycerol from membrane phospholipids, also induced ODC activity; 0.02 units of phospholipase C per ml led to about a 50-fold increase in ODC activity at 6 h after treatment. Phospholipase A2 was ineffective. Phospholipase C-induced ODC activity correlated with an increased level of ODC mRNA. Furthermore, palmitoylcarnitine, an inhibitor of protein kinase C, inhibited epidermal ODC induction and the increased level of ODC mRNA by TPA. Also, palmitoylcarnitine inhibited skin tumor promotion by TPA; application of 3 mumol of palmitoylcarnitine in conjunction with each promotional treatment with 10 nmol of TPA to the initiated skin of female CD-1 mice inhibited tumor formation. Taken together, we conclude that activation of protein kinase C may be an early event in ODC gene transcription and skin tumor promotion by TPA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3779635

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

Review 1.  Regulation of protein kinase C activity by various lipids.

Authors:  A A Farooqui; T Farooqui; A J Yates; L A Horrocks
Journal:  Neurochem Res       Date:  1988-06       Impact factor: 3.996

2.  Hydrolysis of inositol phospholipids precedes cellular proliferation in asbestos-stimulated tracheobronchial epithelial cells.

Authors:  A Sesko; M Cabot; B Mossman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

3.  Superinduction of mouse epidermal ornithine decarboxylase activity by repeated 12-o-tetradecanoylphorbol-13-acetate treatments.

Authors:  A K Verma; K M Hsiao; H Ahrens; M Suganuma; H Fujiki; S Matsufuji; H Hayashi
Journal:  Mol Cell Biochem       Date:  1996-02-23       Impact factor: 3.396

4.  Reactive oxygen in the tumor promotion stage of skin carcinogenesis.

Authors:  S M Fischer; G S Cameron; J K Baldwin; D W Jasheway; K E Patrick
Journal:  Lipids       Date:  1988-06       Impact factor: 1.880

5.  Protein kinase C transduces the signal for Langerhans' cell migration from the epidermis.

Authors:  G M Halliday; A D Lucas
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

Review 6.  Protein kinase C family: on the crossroads of cell signaling in skin and tumor epithelium.

Authors:  D Breitkreutz; L Braiman-Wiksman; N Daum; M F Denning; T Tennenbaum
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-28       Impact factor: 4.553

7.  Lack of 12-O-tetradecanoylphorbol-13-acetate responsiveness of ornithine decarboxylase introns which have AP-1 consensus sequences.

Authors:  C P Tseng; A K Verma
Journal:  Mol Cell Biochem       Date:  1995-05-10       Impact factor: 3.396

8.  The cellular response to induction of the p21 c-Ha-ras oncoprotein includes stimulation of jun gene expression.

Authors:  L Sistonen; E Hölttä; T P Mäkelä; J Keski-Oja; K Alitalo
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.